To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class.

Trial Profile

To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Cyclophosphamide (Primary) ; Tacrolimus (Primary)
  • Indications Lupus nephritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top